Preliminary experiments show conolidine may inhibit unique ion channels, reducing neuronal excitability and restricting soreness alerts. This mechanism is especially applicable in neuropathic discomfort, in which abnormal signaling will cause persistent pain. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways